Jim Simons X Biotech Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.02 - $5.81 $52,452 - $75,808	-13,048 Reduced 46.05%	15,287 $63,000
Q2 2023 Aug 11, 2023	SELL	$3.06 - $6.38 $73,929 - $154,140	-24,160 Reduced 46.02%	28,335 $168,000
Q1 2023 May 12, 2023	SELL	$3.22 - $4.72 $157,693 - $231,152	-48,973 Reduced 48.26%	52,495 $181,000
Q4 2022 Feb 13, 2023	SELL	$3.03 - $3.79 $163,620 - $204,660	-54,000 Reduced 34.73%	101,468 $356,000
Q3 2022 Nov 14, 2022	BUY	$3.58 - $5.88 $274,944 - $451,584	76,800 Added 97.63%	155,468 $563,000
Q2 2022 Aug 12, 2022	BUY	$5.13 - $9.2 $403,566 - $723,745	78,668 New	78,668 $443,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.